<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02965742</url>
  </required_header>
  <id_info>
    <org_study_id>2015-A00596-43</org_study_id>
    <nct_id>NCT02965742</nct_id>
  </id_info>
  <brief_title>Clinical Evaluation Of An X-Ray Bone Densitometer:Use Of DXA Technology For Precise Assessment Of Human Body Composition</brief_title>
  <official_title>Clinical Evaluation Of An X-Ray Bone Densitometer: Use Of DXA Technology For Precise Assessment Of Body Composition In Humans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Diagnostic Medical Systems</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Diagnostic Medical Systems</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objectives of this study are:&#xD;
&#xD;
        -  to assess the concordance of body composition measures between two bone densitometry&#xD;
           devices: the STRATOS by Diagnostic Medical Systems (DMS) and the Hologic QDR 4500 A by&#xD;
           Hologic inc.&#xD;
&#xD;
        -  to assess the concordance of body composition measures between two bone densitometry&#xD;
           devices: the STRATOS by Diagnostic Medical Systems (DMS) and the Hologic HORIZON A by&#xD;
           Hologic inc.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The secondary objectives of this study are:&#xD;
&#xD;
        -  the assessment of the consistency of body composition measurements at local level (arms,&#xD;
           trunk, legs) between the Stratos and Hologic 4500 A,&#xD;
&#xD;
        -  the assessment of the consistency of body composition measurements at local level (arms,&#xD;
           trunk, legs) between the Stratos and Hologic HORIZON A,&#xD;
&#xD;
        -  Monitoring the evolution of body composition in patients receiving at least two&#xD;
           evaluations of DXA Hologic QDR 4500A on: patients treated for obesity or anorexia&#xD;
           nervosa, sports people and other patient with prescription DXA and the assessment the&#xD;
           consistency of body composition measurements in terms,&#xD;
&#xD;
        -  Monitoring the evolution of body composition in patients receiving at least two&#xD;
           evaluations of DXA Hologic HORIZON A on: patients treated for obesity or anorexia&#xD;
           nervosa, sports people and other patient with prescription DXA and the assessment the&#xD;
           consistency of body composition measurements in terms.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2016</start_date>
  <completion_date type="Anticipated">January 2020</completion_date>
  <primary_completion_date type="Anticipated">July 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Lin concordance coefficient</measure>
    <time_frame>Day 0</time_frame>
    <description>In order to get a first idea of the adequacy of the two techniques measurements of the two bone densitometers, a calculation of intraclass correlation coefficients will be done. To supplement this data, a correlation study between the two techniques will be performed. For this we will use the Bland-Altman technique and a study of LIN concordance correlation coefficient</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Osteodensitometry</condition>
  <arm_group>
    <arm_group_label>The study population: first 25 patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The study population consists of patients referred to the Nuclear Medicine and Medical Biophysics Department of the Montpellier University Hospital for the performance of an osteodensitometric examination.&#xD;
Intervention: Whole body and sub-regions exams using the &quot;Stratos&quot; Intervention: Whole body and sub-regions exams using the &quot;Hologic QDR 4500A&quot; Intervention: Whole body and sub-regions exams using the &quot;Hologic HORIZON A&quot;</description>
  </arm_group>
  <arm_group>
    <arm_group_label>The study population: last 25 patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The study population consists of sportsmen patients referred to the Nuclear Medicine and Medical Biophysics Department of the Montpellier University Hospital for the performance of an osteodensitometric examination.&#xD;
Intervention: Whole body and sub-regions exams using the &quot;Stratos&quot; Intervention: Whole body and sub-regions exams using the &quot;Hologic QDR 4500A&quot; Intervention: Whole body and sub-regions exams using the &quot;Hologic HORIZON A&quot;</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Stratos</intervention_name>
    <description>A machine made by DMS group.</description>
    <arm_group_label>The study population: first 25 patients</arm_group_label>
    <arm_group_label>The study population: last 25 patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>&quot;Hologic QDR 4500A&quot;</intervention_name>
    <description>A machine made by Hologic inc.</description>
    <arm_group_label>The study population: first 25 patients</arm_group_label>
    <arm_group_label>The study population: last 25 patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>&quot;Hologic HORIZON A&quot;</intervention_name>
    <description>A machine made by Hologic inc.</description>
    <arm_group_label>The study population: first 25 patients</arm_group_label>
    <arm_group_label>The study population: last 25 patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The patient must have given his/her informed and signed consent&#xD;
&#xD;
          -  The patient must be insured or beneficiary of a health insurance plan&#xD;
&#xD;
          -  The patient is referred by a doctor for the performance of an osteodensitometry&#xD;
             examination or sportsmen coming through a protocol where the nuclear medicine&#xD;
             department is the investigator center&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  The patient is pregnant or nursing&#xD;
&#xD;
          -  The patient is unable to sign or refuse to sign the informed consent&#xD;
&#xD;
          -  The patient has a coronary stent or metal sutures in the heart&#xD;
&#xD;
          -  The patient has any type of metal objects in the body such as an artificial joint, a&#xD;
             pin or a metal plate&#xD;
&#xD;
          -  The patient has a pacemaker or defibrillator&#xD;
&#xD;
          -  Patient weighing more than 200 kg or more than 2 meters high by 65 centimeters wide&#xD;
&#xD;
          -  The patient is using an insulin pump or with insulin-necked&#xD;
&#xD;
          -  The patient has undergone X-ray examination using a contrast medium such as barium in&#xD;
             the previous seven days visit,&#xD;
&#xD;
          -  Patient who underwent an examination using x rays in the 15 days preceding the visit&#xD;
&#xD;
          -  Patient suffering from generalized edema&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Denis MARIANO-GOULART, Phd.Medecine</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nuclear department</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laurent MAIMOUN, Phd.</last_name>
    <phone>0467338464</phone>
    <phone_ext>+33</phone_ext>
    <email>l-maimoun@chu-montpellier.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sana EL OUAZGHARI, Bsc.</last_name>
    <phone>0466271059</phone>
    <phone_ext>+33</phone_ext>
    <email>selouazghari@dms-imaging.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Montpellier</name>
      <address>
        <city>Montpellier</city>
        <state>Hérault</state>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurent MAIMOUN, Phd</last_name>
      <phone>0467338464</phone>
      <phone_ext>+33</phone_ext>
      <email>l-maimoun@chu-montpellier.fr</email>
    </contact>
    <investigator>
      <last_name>Denis MARIANO-GOULART, Phd.Medecine</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aurélie BOURDON, Phd.Medecine</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>November 10, 2016</study_first_submitted>
  <study_first_submitted_qc>November 14, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 17, 2016</study_first_posted>
  <last_update_submitted>March 13, 2019</last_update_submitted>
  <last_update_submitted_qc>March 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 14, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>DXA</keyword>
  <keyword>DMS</keyword>
  <keyword>DMS Imaging</keyword>
  <keyword>STRATOS</keyword>
  <keyword>Horizon A</keyword>
  <keyword>QDR4500A</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

